12/3
08:44 am
cybn
Cybin (OTCMKTS:CYBN) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Cybin (OTCMKTS:CYBN) had its "buy" rating reaffirmed by analysts at Guggenheim.
11/20
08:10 pm
cybn
Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges [Yahoo! Finance]
Medium
Report
Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges [Yahoo! Finance]
11/20
11:04 am
cybn
Cybin (OTCMKTS:CYBN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $70.00 to $45.00. They now have a "buy" rating on the stock.
Low
Report
Cybin (OTCMKTS:CYBN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $70.00 to $45.00. They now have a "buy" rating on the stock.
11/14
01:59 pm
cybn
Cybin (OTCMKTS:CYBN) had its price target lowered by analysts at HC Wainwright from $150.00 to $55.00. They now have a "buy" rating on the stock.
Low
Report
Cybin (OTCMKTS:CYBN) had its price target lowered by analysts at HC Wainwright from $150.00 to $55.00. They now have a "buy" rating on the stock.
11/14
05:31 am
cybn
Fibroblast Growth Factors Market Global Forecast Report 2025-2030: Opportunities in Regenerative Medicine, Oncology, and Metabolic Disorders Due to Advances in Molecular Biology, Delivery Technologies [Yahoo! Finance]
Low
Report
Fibroblast Growth Factors Market Global Forecast Report 2025-2030: Opportunities in Regenerative Medicine, Oncology, and Metabolic Disorders Due to Advances in Molecular Biology, Delivery Technologies [Yahoo! Finance]
11/13
03:12 pm
cybn
Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript [Seeking Alpha]
Low
Report
Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript [Seeking Alpha]
11/13
08:17 am
cybn
Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights [Yahoo! Finance]
11/13
07:40 am
cybn
Cybin reports Q2 results [Seeking Alpha]
Medium
Report
Cybin reports Q2 results [Seeking Alpha]
11/13
07:20 am
cybn
Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
Medium
Report
Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
11/12
07:30 am
cybn
Cybin to Participate in the Jefferies Global Healthcare Conference in London
Low
Report
Cybin to Participate in the Jefferies Global Healthcare Conference in London
11/6
07:30 am
cybn
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
Low
Report
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
11/5
07:30 am
cybn
Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Medium
Report
Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
11/4
11:00 am
cybn
Compass Pathways to expedite launch of its experimental depression therapy [Yahoo! Finance]
Medium
Report
Compass Pathways to expedite launch of its experimental depression therapy [Yahoo! Finance]
11/3
07:30 am
cybn
Cybin to Participate at the 2025 Milken Institute Future of Health Summit
Medium
Report
Cybin to Participate at the 2025 Milken Institute Future of Health Summit
10/31
04:19 pm
cybn
Cybin Announces Closing of $175 Million Registered Direct Offering
Medium
Report
Cybin Announces Closing of $175 Million Registered Direct Offering
10/28
08:00 am
cybn
Cybin Announces $175 Million Registered Direct Offering
High
Report
Cybin Announces $175 Million Registered Direct Offering
10/23
02:30 pm
cybn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
10/18
10:00 am
cybn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
10/13
01:50 pm
cybn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
10/8
05:44 pm
cybn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
10/3
10:00 am
cybn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
9/28
10:00 am
cybn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
9/24
04:38 pm
cybn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
9/23
05:04 pm
cybn
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones [Yahoo! Finance]
Medium
Report
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones [Yahoo! Finance]
9/23
05:00 pm
cybn
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones
Medium
Report
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones